Literature DB >> 23921258

Immunity to amoeba.

Barbara Nowak1, Victoria Valdenegro-Vega2, Philip Crosbie2, Andrew Bridle2.   

Abstract

Amoebic infections in fish are most likely underestimated and sometimes overlooked due to the challenges associated with their diagnosis. Amoebic diseases reported in fish affect either gills or internal organs or may be systemic. Host response ranges from hyperplastic response in gill infections to inflammation (including granuloma formation) in internal organs. This review focuses on the immune response of Atlantic salmon to Neoparamoeba perurans, the causative agent of Amoebic Gill Disease (AGD).
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amoeba; Antibody; Gene expression; Immune; Salmon

Mesh:

Year:  2013        PMID: 23921258     DOI: 10.1016/j.dci.2013.07.021

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  4 in total

1.  A comparison of disease susceptibility and innate immune response between diploid and triploid Atlantic salmon (Salmo salar) siblings following experimental infection with Neoparamoeba perurans, causative agent of amoebic gill disease.

Authors:  Lynn Chalmers; John F Taylor; William Roy; Andrew C Preston; Herve Migaud; Alexandra Adams
Journal:  Parasitology       Date:  2017-05-11       Impact factor: 3.234

2.  In vitro gill cell monolayer successfully reproduces in vivo Atlantic salmon host responses to Neoparamoeba perurans infection.

Authors:  Irene Cano; Nick Gh Taylor; Amanda Bayley; Susie Gunning; Robin McCullough; Kelly Bateman; Barbara F Nowak; Richard K Paley
Journal:  Fish Shellfish Immunol       Date:  2018-11-17       Impact factor: 4.581

Review 3.  Experimental Challenge Models and In Vitro Models to Investigate Efficacy of Treatments and Vaccines against Amoebic Gill Disease.

Authors:  Jemma Hudson; Barbara F Nowak
Journal:  Microorganisms       Date:  2021-03-30

Review 4.  To React or Not to React: The Dilemma of Fish Immune Systems Facing Myxozoan Infections.

Authors:  Astrid S Holzer; M Carla Piazzon; Damien Barrett; Jerri L Bartholomew; Ariadna Sitjà-Bobadilla
Journal:  Front Immunol       Date:  2021-09-16       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.